ISPOR CEO Rob Abbott on HTA-integrated trial design, digital twin evidence gaps, SaMD’s continuous update problem, and the one change he’d mandate for clinical tech.
- HEOR, AI, And The Future Of Clinical Trial Technology
- AI Amplifies Capabilities But Also Risks: Learn The Legal Consequences Of AI In Clinical Research
- Is It Time To Replace RECIST — Or Just Add AI?
- Clinical Research Has System Sprawl Problem
- How Clinical Trial Sites Must Adapt To The Predictive Analytics Era
- Why Patients Drop Out And How To Stop Them
- Predictive Analytics Is Reshaping How Sponsors Run Clinical Trials
- AI In Clinical Trials: Real Impact, Real Limits, What's Next
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Mitigating Study Risk With Performance Analytics
Performance metrics for supporting risk-based management can be great, however, this author tells readers why collecting and analyzing data after a study has begun may not be the best approach.
-
Paving The Way For Virtual Trials In Neurology: A Fully Remote ALS Study
The COVID-19 pandemic has completely changed the way we think about clinical research and care. Clinical trials, a vital component of the drug development process, were heavily disrupted because patients, often with weakened immune systems, could not visit hospitals and research sites.
-
Enhancing Oncology Trials With Clinical Platform Solutions
This example involves a top 10 pharmaceutical company and explores how they were able to improve oncology trial efficiency, safety, patient experience, and more using a platform approach.
-
Bringing Intelligence Into The Flow Of Clinical Trials
AI-driven trial intelligence turns complex data into real-time insight, enabling earlier risk detection, stronger oversight, and smarter decisions across the trial lifecycle.
-
Managing Drug And Data Requirements In Decentralized Clinical Trials
Running a global decentralized clinical trial requires a deep understanding of the differences in FDA and EMA requirements for investigational products and patient data.
-
Supporting Early Phase Oncology Research With The Right Data Management System
Better understand how the evolving landscape drives innovation, why your data capture strategy needs the right technology foundation, and what to look for in a CDMS/EDC system for early-phase oncology.
-
Increase Participant Diversity With eClinical Tools
The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.
-
How To Budget For Site Payments Success
Unearth how bringing the functions of medical writing, clinical data management, and electronic data capture can positively impact the creation of a budget and payment process.
-
Driving Successful Obesity Drug Development With GLP-1 Agonists
GLP-1 agonists are revolutionizing obesity treatment. Signant Health's ePRO solutions support over 30 trials, providing critical patient data and driving successful approvals.
-
Rewind The Clock And Take TMF Back To Basics
Consider the evolution of Trial Master Files (TMF) in clinical trials when tackling the paradigm of maintaining simplicity while embracing technology.
RECENT NEWSLETTERS
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More
- 04.09.26 -- AI In Clinical Trials: Recruitment, eCOA Risks & Data
- 04.04.26 -- Your March Briefing: The Best In Clinical Trial Tech
- 04.02.26 -- AI Is Reshaping Clinical Trials: Here's How to Keep Up